David Arkadir
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Inherent variability limits clinical utility of reproducible Parkinson's transcriptomics signatures.
Inherent variability limits clinical utility of reproducible Parkinson's transcriptomics signatures.
Journal: NPJ Parkinson's disease
Published: September 30, 2025
A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's disease.
Journal: IBRO neuroscience reports
Published: September 09, 2025
Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls.
Journal: Life (Basel, Switzerland)
Published: April 21, 2025
Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.
Journal: Parkinsonism & related disorders
Published: March 09, 2025
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease.
Journal: Journal of Parkinson's disease
Published: February 17, 2025
Compressive Cervical Myelopathy Causing Impaired Gait after Deep Brain Stimulation Is Not Rare.
Journal: Movement disorders clinical practice
Published: December 16, 2024
Genetic Etiology Influences the Low-Frequency Components of Globus Pallidus Internus Electrophysiology in Dystonia.
Journal: European journal of neurology
Published: November 08, 2024
Multiparametric quantitative MRI uncovers putamen microstructural changes in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: August 15, 2024
Investigating the Relationship between Chronic Liver Cirrhosis and Parkinsonism: A Comparative Analysis and a Suggested Diagnostic Scheme.
Journal: Clinics and practice
Published: June 17, 2024
Low prevalence of SCA27B in adult-onset cerebellar ataxia cohort of Jewish ancestry.
Journal: Parkinsonism & related disorders
Published: May 10, 2024
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study.
Journal: Advances in therapy
Published: April 08, 2024
Last Updated: 09/26/2026